Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth


#165774

N/A

GBI Research

$ 3500

In Stock

 

Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth

 

Adult and Adolescent Vaccines Market to 2018. The report provides insights into the vaccines in the adult and adolescent vaccines market, including market forecasts up to 2018. It provides an in-depth analysis of the vaccines for the adult and adolescent market, as well as insights into the adult and adolescent vaccines market’s Research and Development (R&D) pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global adult and adolescent vaccines market. 

 

The report analyzes the market for adult and adolescent vaccines in the US, and the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. The report discusses the global pipeline for adult and adolescent vaccines across various stages of development. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. 

 

GBI Research found that the adult and adolescent vaccines market in the top seven markets was valued at $7.2 billion in 2011, increasing at a Compound Annual Growth Rate (CAGR) of 6.9% during the 2007–2011 historic period. The market is projected to witness a growth of 5.6% during the 2011–2018 forecast period to reach $10.5 billion. 

 

The growth in the adult and adolescent vaccines market is driven by increased uptake of pneumococcal vaccines such as Prevnar 13 which got approved for use in people aged 50 and older. The pneumococcal vaccines market is expected to grow at a CAGR of 19% during the forecast period and reach $1.7 billion in 2018, from $0.5 billion in 2011.

 

Scope

 

  • Annualized market data for the adult and adolescent vaccines market from 2007 to 2011, forecast forward to 2018
  • Analysis of the adult and adolescent vaccines market in the leading geographies of the world, which includes the US, the UK, Germany, France, Italy, Spain, and Japan
  • Market characterization of the adult and adolescent vaccines market including market size and cost of vaccination
  • Key drivers and barriers that have a significant impact on the market
  • Coverage of pipeline molecules in various phases of vaccine development
  • Competitive benchmarking of leading companies. Key companies studied in this report are GlaxoSmithKline, Sanofi, Pfizer, Merck and Novartis.
  • Key M&A activities and licensing agreements that have taken place between 2009 and up to November 2012 in the global adult and adolescent vaccines market.

 

Reasons to Buy

 

  • Align your product portfolio to the markets with the highest growth potential
  • Develop market-entry and market expansion strategies by identifying the potential regions and adult and adolescent vaccines market segments poised for strong growth
  • Create a more specifically-tailored country strategy through the understanding of key drivers and barriers of the global adult and adolescent vaccines market
  • Develop key strategic initiatives by understanding the key focus areas and top-selling products of leading companies
  • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Table of Contents
 

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

 

2 Adult and Adolescent Vaccines Market to 2018: Introduction

2.1 Overview

 

3 Adult and Adolescent Vaccines Market to 2018: Overview

3.1 Vaccine Preventable Diseases

3.1.1 Types of Vaccines

3.2 Recommendations for Immunization

3.2.1 The US

3.2.2 Top Five European Countries

3.2.3 Japan

3.3 Regulatory Framework

3.3.1 The US

3.3.2 Top Five European Countries

3.3.3 Japan

3.4 Vaccine Manufacturing Process

 

4 Adult and Adolescent Vaccines Market to 2018: Market Characterization and Forecast

4.1 Revenue Forecast

4.2 Market Share by Type of Vaccines

4.3 Market Share by Geography

4.4 Drivers

4.4.1 Adult Vaccines Segment to Drive Future Growth

4.4.2 High Unmet Needs

4.4.3 Targeting New Diseases Areas for Vaccines Likely To Drive the Market

4.4.4 Novel Vaccine Technologies

4.5 Restraints

4.5.1 Production Capacity Limitations

4.5.2 High Initial Capital Investments and Technical Expertise

4.5.3 Regulations Delay Vaccine Launch and Acceptance


5 Adult and Adolescent Vaccines Market to 2018: Influenza Vaccines

5.1 Disease Overview

5.2 Market Forecasts

5.2.1 The US

5.2.2 Top Five European Countries

5.2.3 Japan

5.3 Cost of Vaccination

5.3.1 The US

5.3.2 Top Five European Countries

5.3.3 Japan

5.4 Pipeline Analysis – Influenza Vaccines

 

6 Adult and Adolescent Vaccines Market to 2018: Tetanus, Diphtheria and Pertussis Vaccines

6.1 Disease Overview

6.2 Market Forecasts

6.2.1 The US

6.2.2 Top Five European Countries

6.2.3 Japan

6.3 Cost of Vaccination

6.3.1 The US

6.3.2 Top Five European Countries

6.3.3 Japan

6.4 Pipeline Analysis – Tetanus, Diphtheria, Pertussis (Td/Tdap) Vaccines

 

7 Adult and Adolescent Vaccines Market to 2018: Pneumococcal Vaccines

7.1 Disease Overview

7.2 Market Forecasts

7.2.1 The US

7.2.2 Top Five European Countries

7.2.3 Japan

7.3 Cost of Vaccination

7.3.1 The US

7.3.2 Top Five European Countries

7.3.3 Japan

7.4 Pipeline Analysis – Pneumococcal Vaccines

 

8 Adult and Adolescent Vaccines Market to 2018: Meningococcal Vaccines

8.1 Disease Overview

8.2 Market Forecasts

8.2.1 The US

8.2.2 Top Five European Countries

8.3 Cost of Vaccination

8.3.1 The US

8.3.2 Top Five European Countries

8.4 Pipeline Analysis – Meningococcal Vaccines

 

9 Adult and Adolescent Vaccines Market to 2018: Human Papilloma Virus Vaccines

9.1 Disease Overview

9.2 Market Forecasts

9.2.1 The US

9.2.2 Top Five European Countries

9.2.3 Japan

9.3 Cost of Vaccination

9.3.1 The US

9.3.2 Top Five European Countries

9.3.3 Japan

9.4 Pipeline Analysis – Human Papillomavirus Vaccines

 

10 Adult and Adolescent Vaccines Market to 2018: Hepatitis Vaccines

10.1 Disease Overview

10.2 Market Forecasts

10.2.1 The US

10.2.2 Top Five European Countries

10.2.3 Japan

10.3 Cost of Vaccination

10.3.1 The US

10.3.2 Top Five European Countries

10.3.3 Japan

10.4 Pipeline Analysis – Hepatitis Vaccines

 

11 Adult and Adolescent Vaccines Market to 2018: Measles, Mumps and Rubella Vaccines

11.1 Disease Overview

11.2 Market Forecasts

11.2.1 The US

11.2.2 Top Five European Countries

11.2.3 Japan

11.3 Cost of Vaccination

11.3.1 The US

11.3.2 Top Five European Countries

11.3.3 Japan

 

12 Adult and Adolescent Vaccines Market to 2018: Zoster Vaccines

12.1 Disease Overview

12.2 Market Forecasts

12.2.1 The US

12.2.2 The UK

12.3 Cost of Vaccination

12.3.1 The US

12.3.2 The UK

12.4 Pipeline Analysis – Zoster Vaccines

 

13 Adult and Adolescent Vaccines Market to 2018: Varicella Vaccines

13.1 Disease Overview

13.2 Market Forecasts

13.2.1 The US

13.2.2 Top Five European Countries

13.2.3 Japan

13.3 Cost of Vaccination

13.3.1 The US

13.3.2 Top Five European Countries

13.3.3 Japan

13.4 Pipeline Analysis – Varicella Vaccines

 

14 Adult and Adolescent Vaccines Market to 2018: Competitive Landscape

14.1 Introduction

14.2 Major Company Profiles

14.2.1 GlaxoSmithKline

14.2.2 Sanofi

14.2.3 Pfizer

14.2.4 Merck

14.2.5 Novartis

 

15 Adult and Adolescent Vaccines Market to 2018: Strategic Consolidations

15.1 Deals by Year

15.2 Deals by Type

15.3 Deals by Value

15.4 Deals by Geography

15.5 Summary of Major M&A Deals

15.6 Summary of Major Licensing Deals

15.7 Summary of Major Partnerships

 

16 Adult and Adolescent Vaccines Market to 2018: Appendix

16.1 Market Definitions

16.2 Abbreviations

16.3 Bibliography

16.4 Research Methodology

16.4.1 Coverage

16.4.2 Secondary Research

16.4.3 Primary Research

16.4.4 Model for Estimation of Vaccine Market

16.5 Geographical Landscape

16.6 Pipeline Analysis

16.7 Competitive Landscape

16.7.1 Expert Panel Validation

16.8 Contact Us

16.9 Disclaimer

 

Table 1: Adult and Adolescent Vaccines Market to 2018, Vaccine-preventable Diseases, 2012

Table 2: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Revenue ($bn), 2007–2011

Table 3: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Revenue Forecast ($bn), 2011–2018

Table 4: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, the US, Revenue ($m), 2007–2011

Table 5: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, The US, Revenue Forecast ($m), 2011–2018

Table 6: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Revenue ($m), 2007–2011

Table 7: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011–2018

Table 8: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Revenue ($m), 2007–2011

Table 9: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Revenue Forecast ($m), 2011–2018

Table 10: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, the US, Cost of Vaccination ($), 2007–2011

Table 11: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, the US, Cost of Vaccination Forecast ($), 2011–2018

Table 12: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007–2011

Table 13: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011–2018

Table 14: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Cost of Vaccination ($), 2007–2011

Table 15: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Cost of Vaccination Forecast ($), 2011–2018

Table 16: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Global, Pipeline by Phase, 2012

Table 17: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Revenue ($m), 2007–2011

Table 18: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Revenue Forecast ($m), 2011–2018

Table 19: Adult and Adolescent Vaccines Market to 2018, Td/ Tdap, Top Five European Countries, Revenue ($m), 2007–2011

Table 20: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Top Five European Countries, Revenue Forecast ($m), 2011–2018

Table 21: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Revenue ($m), 2007–2011

Table 22: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Revenue Forecast ($m), 2011–2018

Table 23: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Cost of Vaccination ($), 2007–2011

Table 24: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Cost of Vaccination Forecast ($), 2011–2018

Table 25: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Top Five European Countries, Cost of Vaccination ($), 2007–2011

Table 26: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Top Five European Countries, Cost of Vaccination Forecast ($), 2011–2018

Table 27: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Cost of Vaccination ($), 2007–2011

Table 28: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Cost of Vaccination Forecast ($), 2011–2018

Table 29: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Global, Pipeline by Phase, 2012

Table 30: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Revenue ($m), 2007–2011

Table 31: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Revenue Forecast ($m), 2011–2018

Table 32: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Revenue ($m), 2007–2011

Table 33: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011–2018

Table 34: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Revenue ($m), 2007–2011

Table 35: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Revenue Forecast ($m), 2011–2018

Table 36: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Cost of Vaccination ($), 2007–2011

Table 37: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Cost of Vaccination Forecast ($), 2011–2018

Table 38: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007–2011

Table 39: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011–2018

Table 40: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Cost of Vaccination ($), 2007–2011

Table 41: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Cost of Vaccination Forecast ($), 2011–2018

Table 42: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Global, Pipeline by Phase, 2012

Table 43: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Revenue ($m), 2007–2011

Table 44: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Revenue Forecast ($m), 2011–2018

Table 45: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Revenue ($m), 2007–2011

Table 46: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011–2018

Table 47: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Cost of Vaccination ($), 2007–2011

Table 48: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Cost of Vaccination Forecast ($), 2011–2018

Table 49: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007–2011

Table 50: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011–2018

Table 51: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Global, Pipeline by Phase, 2012

Table 52: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Revenue ($m), 2007–2011

Table 53: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Revenue Forecast ($m), 2011–2018

Table 54: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Revenue ($m), 2007–2011

Table 55: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011–2018

Table 56: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Japan, Revenue Forecast ($m), 2010–2018

Table 57: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Cost of Vaccination ($), 2007–2011

Table 58: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Cost of Vaccination Forecast ($), 2011–2018

Table 59: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007–2011

Table 60: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011–2018

Table 61: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Japan, Cost of Vaccination Forecast ($), 2009–2018

Table 62: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Global, Pipeline by Phase (%), 2012

Table 63: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Revenue ($m), 2007–2011

Table 64: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Revenue Forecast ($m), 2011–2018

Table 65: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Revenue ($m), 2007–2011

Table 66: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011–2018

Table 67: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Revenue ($m), 2007–2011

Table 68: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Revenue Forecast ($m), 2011–2018

Table 69: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Cost of Vaccination ($), 2007–2011

Table 70: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Cost of Vaccination Forecast ($), 2011–2018

Table 71: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007–2011

Table 72: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011–2018

Table 73: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Cost of Vaccination ($), 2007–2011

Table 74: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Cost of Vaccination Forecast ($), 2011–2018

Table 75: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Global, Pipeline by Phase, 2012

Table 76: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Revenue ($m), 2007–2011

Table 77: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Revenue Forecast ($m), 2011–2018

Table 78: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Revenue ($m), 2007–2011

Table 79: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011–2018

Table 80: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Japan, Revenue ($m), 2007–2011

Table 81: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Japan, Revenue Forecast ($m), 2011–2018

Table 82: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Cost of Vaccination ($), 2007–2011

Table 83: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Cost of Vaccination Forecast ($), 2011–2018

Table 84: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007–2011

Table 85: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011–2018

Table 86: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007–2011

Table 87: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011–2018

Table 88: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Revenue ($m), 2007–2011

Table 89: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Revenue Forecast ($m), 2011–2018

Table 90: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the UK, Revenue Forecast ($m), 2011–2018

Table 91: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Cost of Vaccination ($), 2007–2011

Table 92: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Cost of Vaccination Forecast ($), 2011–2018

Table 93: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the UK, Cost of Vaccination Forecast ($), 2012–2018

Table 94: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, Global, Pipeline by Phase, 2012

Table 95: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Revenue ($m), 2007–2011

Table 96: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Revenue Forecast ($m), 2011–2018

Table 97: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Revenue ($m), 2007–2011

Table 98: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011–2018

Table 99: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Japan, Revenue ($m), 2007–2011

Table 100: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Japan, Revenue Forecast ($m), 2011–2018

Table 101: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Cost of Vaccination ($), 2007–2011

Table 102: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Cost of Vaccination Forecast ($), 2011–2018

Table 103: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007–2011

Table 104: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011–2018

Table 105: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Japan, Cost of Vaccination ($), 2007–2011

Table 106: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011–2018

Table 107: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Global, Pipeline by Phase, 2012

 

Figure 1: Adult and Adolescent Vaccines Market to 2018, Global, Types of Vaccines, 2012

Figure 2: Adult and Adolescent Vaccines Market to 2018, The US, Recommendations for Immunization (19–65+ Years), 2012

Figure 3: Adult and Adolescent Vaccines Market to 2018, the US, Recommendations for Immunization (7–18 Years), 2012

Figure 4: Adult and Adolescent Vaccines Market to 2018, Top Five European Countries, Recommendations for Immunization, 2012

Figure 5: Adult and Adolescent Vaccines Market to 2018, Japan, Recommendations for Immunization (Under 20 Years of Age), 2011

Figure 6: Adult and Adolescent Vaccines Market to 2018, Global, Vaccine Manufacturing Process, 2012

Figure 7: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Revenue Forecast ($bn), 2007–2018

Figure 8: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Market Share by Type of Vaccines (%), 2011

Figure 9: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Market Share by Geography (%), 2011

Figure 10: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, the US, Revenue Forecast ($m), 2007–2018

Figure 11: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007–2018

Figure 12: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Revenue Forecast ($m), 2007–2018

Figure 13: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Global, Pipeline by Phase (%), 2012

Figure 14: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Revenue Forecast ($m), 2007–2018

Figure 15: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Top Five European Countries, Revenue Forecast ($m), 2007–2018

Figure 16: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Revenue Forecast ($m), 2007–2018

Figure 17: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Global, Pipeline by Phase (%), 2012

Figure 18: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Revenue Forecast ($m), 2007–2018

Figure 19: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007–2018

Figure 20: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Revenue Forecast ($m), 2007–2018

Figure 21: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Global, Pipeline by Phase (%), 2012

Figure 22: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Revenue Forecast ($m), 2007–2018

Figure 23: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007–2018

Figure 24: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Global, Pipeline by Phase (%), 2012

Figure 25: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Revenue Forecast ($m), 2007–2018

Figure 26: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007–2018

Figure 27: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Japan, Revenue Forecast ($m), 2010–2018

Figure 28: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Global, Pipeline by Phase (%), 2012

Figure 29: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Revenue Forecast ($m), 2007–2018

Figure 30: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007–2018

Figure 31: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Revenue Forecast ($m), 2007–2018

Figure 32: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Global, Pipeline by Phase (%), 2012

Figure 33: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Revenue Forecast ($m), 2007–2018

Figure 34: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007–2018

Figure 35: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Japan, Revenue Forecast ($m), 2007–2018

Figure 36: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Revenue Forecast ($m), 2007–2018

Figure 37: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, Global, Pipeline by Phase (%), 2012

Figure 38: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Revenue Forecast ($m), 2007–2018

Figure 39: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007–2018

Figure 40: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Japan, Revenue Forecast ($m), 2007–2018

Figure 41: Adult and Adolescent Vaccines Market to 2018, GSK, SWOT Analysis, 2012

Figure 42: Adult and Adolescent Vaccines Market to 2018, Sanofi, SWOT Analysis, 2012

Figure 43: Adult and Adolescent Vaccines Market to 2018, Pfizer, SWOT Analysis, 2012

Figure 44: Adult and Adolescent Vaccines Market to 2018, Merck, SWOT Analysis, 2012

Figure 45: Adult and Adolescent Vaccines Market to 2018, Novartis, SWOT Analysis, 2012

Figure 46: Adult and Adolescent Vaccines Market to 2018, Global, Strategic Consolidations, Deals by Year, 2009–2012

Figure 47: Adult and Adolescent Vaccines Market to 2018, Global, Strategic Consolidations, Deals by Type, 2009–2012

Figure 48: Adult and Adolescent Vaccines Market to 2018, Global, Strategic Consolidations, Deals by Value, 2009–2012

Figure 49: Adult and Adolescent Vaccines Market to 2018, Global, Strategic Consolidations, Deals by Geography, 2009–2012

Figure 50: GBI Research Market Forecasting Model